These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 282099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension].
    Philipp T.
    Fortschr Med; 1979 Aug 16; 97(30-31):1315-20. PubMed ID: 468094
    [Abstract] [Full Text] [Related]

  • 3. Sympathetic nervous system and blood-pressure control in essential hypertension.
    Philipp T, Distler A, Cordes U.
    Lancet; 1978 Nov 04; 2(8097):959-63. PubMed ID: 81987
    [Abstract] [Full Text] [Related]

  • 4. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y.
    Jpn Heart J; 1975 Jul 04; 16(4):404-20. PubMed ID: 1152295
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disturbed noradrenergic blood pressure control in normotensive members of hypertensive families.
    Bianchetti MG, Weidmann P, Beretta-Piccoli C, Rupp U, Boehringer K, Link L, Ferrier C.
    Br Heart J; 1984 Mar 04; 51(3):306-11. PubMed ID: 6696808
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension.
    Bianchetti MG, Weidmann P, Beretta-Piccoli C, Ferrier C.
    Kidney Int; 1987 Apr 04; 31(4):956-63. PubMed ID: 3586502
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
    Grimm M, Weidmann P, Meier A, Keusch G, Ziegler W, Glück Z, Beretta-Piccoli C.
    Br Heart J; 1981 Oct 04; 46(4):404-9. PubMed ID: 7295437
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H, Neurohr W, Lüth JB, Philipp T, Distler A.
    Klin Wochenschr; 1983 Jul 01; 61(13):661-7. PubMed ID: 6310204
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.